Roche Custom Biotech

Associated Content

Rapid Qualification Strategy of a Real-Time PCR Mycoplasma Detection Kit for an MSC-based Cell Therapy

Despite the forward progress, a stumbling point for cell and gene therapies has been that the condensed clinical development timelines, complex manufacturing processes, short shelf-life of the products, and supply chain challenges make it difficult for developers to ensure timely testing of quality and safety attributes....Continued

Ensuring Removal of Residual Enzymes in Biomanufacturing – Trypsin and Collagenase

During this Ask the Expert session, we discussed strategies for verifying the removal of residual enzymes used in biomanufacturing, like trypsin and collagenase from the final product. Specific questions included questions regarding sample prep, timing of testing, benefits of using a kit, sensitivity and clinical grade material....Continued

Verifying Removal of Residual Production Enzymes from Your Final Product

This week, Dr. Roger Noble, Ph.D., Lead Technical Support Consultant at Roche Custom Biotech, will be answering your questions regarding strategies for verifying removal of residual enzymes from your final product, including how to use the ELISA-based Roche Residual Protein Trypsin and Liberase kits....Continued

Residual Enzyme Testing – All in one Assay Kits for Liberase and Trypsin

Roche Custom Biotech launched two new products, the Residual Protein Liberase Kit and the Residual Protein Trypsin Kit, to address some of the key challenges associated with current residual enzyme testing methods....Continued

PCR Release Testing for Mycoplasmas Gaining Ground versus Conventional Methods

The webinar provides a good overview of the use of PCR in testing for mycoplasma, advantages over traditional methods, and also what to expect in terms of demonstrating comparability for regulatory authorities....Continued